Brief: Neurometrix Announces Review Of Strategic Options To Promote Growth And Maximize Shareholder Value
13/02/2024 15:31
Feb 13 (Reuters) - NeuroMetrix Inc NURO.O :
* NEUROMETRIX ANNOUNCES REVIEW OF STRATEGIC OPTIONS TO
PROMOTE
GROWTH AND MAXIMIZE SHAREHOLDER VALUE
* PROCESS TO REVIEW STRATEGIC OPTIONS TO PROMOTE GROWTH OF
ITS
QUELL(®) NEUROMODULATION AND DPNCHECK(®) NEURODIAGNOSTIC
BUSINESSES
* AS CO EXPLORES STRATEGIC OPTIONS THERE WILL BE NO CHANGE
IN CO'S
COMMERCIAL OPERATIONS
Source text for Eikon: ID:nGNX6fn1tS
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13